Esteem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-10-2024
- Paid Up Capital ₹ 1.00 M
as on 04-10-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 3.35 Cr
as on 04-10-2024
- Satisfied Charges ₹ 4.65 M
as on 04-10-2024
- Revenue 178.41%
(FY 2021)
- Profit 116.06%
(FY 2021)
- Ebitda -51.98%
(FY 2021)
- Net Worth 46.61%
(FY 2021)
- Total Assets 38.97%
(FY 2021)
About Esteem Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.35 Cr. The company has closed loans amounting to ₹4.65 M, as per Ministry of Corporate Affairs (MCA) records.
Sravani Suryadevara and Ramachandra Rao serve as directors at the Company.
- CIN/LLPIN
U24239TG2005PTC047373
- Company No.
047373
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2005
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Esteem Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sravani Suryadevara  | Managing Director | 27-Jan-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramachandra Rao | Additional Director | 01-Apr-2024 | Current |
Financial Performance of Esteem Laboratories.
Esteem Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 178.41% increase. The company also saw a substantial improvement in profitability, with a 116.06% increase in profit. The company's net worth Soared by an impressive increase of 46.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Esteem Laboratories?
In 2021, Esteem Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Aug 2019 | ₹3.35 Cr | Open |
Andhra Pradesh State Financial Corporation Creation Date: 03 Jun 2010 | ₹1.65 M | Satisfied |
Andhra Pradesh State Financial Corporation Creation Date: 17 Nov 2006 | ₹3.00 M | Satisfied |
How Many Employees Work at Esteem Laboratories?
Unlock and access historical data on people associated with Esteem Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Esteem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esteem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
